Mark Auerbach

Overview

Mr. Auerbach joined RxElite as an independent director in July 2007. Prior to RxElite, Mr. Auerbach had been a board member at Par Pharmaceuticals (NYSE:PRX), a specialty pharmaceutical company, from 1990 to September 2006, with his last position as its executive chairman of the board. Currently, he serves as chairman of the board at Neuro-Hitech, Inc. (NASD: NHPI), a biopharmaceutical company, and as a director and chairman of the audit committee at Optimer Pharmaceuticals (NASD:OPTR). Mr. Auerbach was a partner and a CFO of Central Lewmar LP, a national fine paper merchant with sales of approximately $700M, from 1992 to 2005.